Prostatic Urethral Lift: A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations

Abstract

The prostatic urethral lift (PUL) is a unique, nonthermal approach to treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). It can be conducted under local anesthesia in an outpatient setting. In published clinical studies, most voiding tested patients do not require a catheter. After PUL, patients experience rapid recovery with minimal adverse effects. Average symptom response is significant by 2 weeks, improves through 3 months, and remains stable through 4 years. Erectile and ejaculatory functions are preserved. This treatment represents a desirable solution for many patients who currently have male LUTS secondary to BPH.

Original languageEnglish (US)
Pages (from-to)357-369
Number of pages13
JournalUrologic Clinics of North America
Volume43
Issue number3
DOIs
StatePublished - Aug 1 2016

Keywords

  • Benign prostatic hyperplasia
  • Lower urinary tract symptoms
  • Minimally invasive therapy
  • Prostatic urethral lift
  • Sexual function
  • Surgical therapy

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Prostatic Urethral Lift: A Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia'. Together they form a unique fingerprint.

Cite this